Abstract
Primary aldosteronism is commonly regarded as largely sporadic, but both germline and somatic mutations are increasingly recognized as underlying the condition. Three germline mutations causing familial hyperaldosteronism have been described, dubbed FH I (due to a CYP11B1/CYP11B2 chimera), FH II (localized to chromosome 7p22, exact location of mutation[s] unknown to date), and FH III (reflecting a T158A mutation in the potassium channel subunit KCNJ5). Major contributions (FH I, FH III) have been by Lifton and his associates; more recently they have also described somatic mutations (G151R, L168R) in KCNJ5 in over a third of aldosterone-producing adenomas, with results confirmed, refined, and extended in a much larger study from Europe. These findings have sparked considerable interest, and over the next 12 months a number of additional reports can be confidently expected to throw light on both normal and abnormal adrenocortical zonation and the genesis of primary aldosteronism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Piatidis GP, Kaltsas GA, Androulakis II, et al. High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin Endocrinol (Oxf). 2009;71:772–8.
Grossman C, Schulz T, Rochel M, et al. Transactivation of the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004;151:397–406.
Vogt W, Fischer I, Ebenruth S, et al. Pharmacokinetics of 9-fluorohydrocortisone Arzneimittelforschung 1971, 21:1133–43.
Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11βhydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262–5.
Funder JW. Primary aldosteronism: are we missing the wood for the trees? Hormone Metab Res 2012, in press.
• Carss RJ, Stowasser M, Gordon RD, O’Shaughnessy KM. Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II. J Hum Hypertens. 2011;25:560–4. Interestingly, the recently described high-affinity membrane-located aldosterone binding site (GPR30) is located on chromosome 7p22.
Geller DS, Zhang J, Wisgerhof MV, et al. A novel form of mendelian hypertension featuring non-glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab. 2008;93:3117–23.
•• Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768–72. This seminal contribution demonstrated that somatic rather than germline mutations may cause aldosterone-producing adenomas.
• Oki K, Plonczynski MW, Lam ML, et al. Potassium channel mutant KCNJ5 T158A expression in human HAC-15 cells increases aldosterone synthesis. Endocrinol 2012, in press. Cells transfected with wild-type KCNJ5 as a control may throw light on the enigma of the lower proliferation rate of KCNJ5 mutant transfectants.
Davies LA, Hu C, Guagliardo NA, et al. Task channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci USA. 2008;105:13696.
Stowasser M, Sharman J, Leand R, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab. 2005;90:5070–6.
Bayliss DA, Barrett PQ. Emerging roles for two-pore-domain potassium channels and their therapeutic impact. Trends Pharmacol Sci. 2008;29:566–75.
Heitzmann D, Derand R, Jungbauer S, et al. Invalidation of TASK-1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. Embo J. 2008;27:179–87.
Penton D, Bandulik S, Tauber P, et al. The role of TASK-3 K+ channels in the regulation of aldosterone secretion. Abstract. Presented at the International Aldosterone Conference, Boston, June 2011.
Doi M, Takahashi Y, Komatsu R, et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal hsd3b6. Nat Med. 2010;16:67–74.
Berthon A, Ragazzon B, Batisse M, et al. Constitutive activation of β-catenin causes primary aldosteronism. Abstract. Presented at the International Aldosterone Conference, Boston, June 2011.
Funder J. Medicine: The genetics of primary aldosteronism. Science. 2011;331:685–6.
•• Boulkroun S, Beuschlein F, Gian-Paolo R, et al. Prevalence, clinical and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertens 2012 in press.
Funder JW. The genetics of primary aldosteronism: Chapter two. Hypertension 2012, in press.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funder, J.W. The Genetic Basis of Primary Aldosteronism. Curr Hypertens Rep 14, 120–124 (2012). https://doi.org/10.1007/s11906-012-0255-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11906-012-0255-x